000 01132 a2200349 4500
005 20250513140738.0
264 0 _c19980416
008 199804s 0 0 eng d
022 _a0887-6924
024 7 _a10.1038/sj.leu.2400915
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVicari, A M
245 0 0 _aAcute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis.
_h[electronic resource]
260 _bLeukemia
_cMar 1998
300 _a441-2 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdult
650 0 4 _aHumans
650 0 4 _aLeukemia, Promyelocytic, Acute
_xchemically induced
650 0 4 _aMale
650 0 4 _aMitoxantrone
_xadverse effects
650 0 4 _aMultiple Sclerosis
_xdrug therapy
650 0 4 _aTopoisomerase II Inhibitors
700 1 _aCiceri, F
700 1 _aFolli, F
700 1 _aLanzi, R
700 1 _aColombo, B
700 1 _aComi, G
700 1 _aCamba, L
773 0 _tLeukemia
_gvol. 12
_gno. 3
_gp. 441-2
856 4 0 _uhttps://doi.org/10.1038/sj.leu.2400915
_zAvailable from publisher's website
999 _c9496765
_d9496765